Invest in the Future of UK Health & Wellbeing

“Regulation on a global scale is coming. Cannabinoids are on the verge of being used in toothpaste, beverages, personal care products, and almost anything else you can imagine” Forbes | August 2020

Medicaleaf™ is set to be Europe’s leading provider of health and wellness CBD innovations. A global brand promoting wellness from nature. Medicaleaf will have a 'post-raise' valuation of £20 million with expectations to reach a pre-floatation valuation of £100 million in three years' time, Annual predicted net profit over sales metric of ‘plus 43%'.

DOWNLOAD YOUR INVESTMENT MEMORANDUM MedicalLeaf are already at the forefront of CBD product development and are ready for the impending Gold Rush.

2020 Achievements Created and launched a new wellness CBD brand; 'liift' for the UK and European market Launch and distribution of liift water via e-commerce platform Development of liift CBD Chocolate ready for distribution CBD Oil Range developed ready for launch and distribution Initial Medicinal Cannabis Supplies selected to fulfil prescriptions GP Training programme for Cannabis Based Medicine initiated Commencement of Medicinal Cannabis Treatment Centre rollout

2021/22 Launches Launch of Medicaleaf Intelligent Prescription App/Data Capture App Launch of Cold Brew Coffee Range Launch of CBD Tea Range Launch of CBD Coffee Range Launch of CBD Balms and Active Range Opening of 50 further Medical Cannabis Treatment Centres Launch of CBD Capsules NIHR Medical Trials to Commence

CLICK HERE TO LEARN MORE DOWNLOAD YOUR INVESTMENT MEMORANDUM

Disclaimer: Any person accessing the email and considering potential investment opportunities featured on the email should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor.